Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ImpediMed
Brisbane, Queensland, Australiaimpedimed.com ↗
- Ownership
- Public · IPD
- Employees
- ~67
- Development stage
- Other
01
Overview
ImpediMed’s SOZO Digital Health Platform with L-Dex has demonstrated strong clinical results in the PREVENT trial—the largest randomized controlled trial for lymphedema prevention in breast cancer patients—showing that early detection using BIS and intervention prevented progression to chronic lymphedema in over 92% of cases. The technology has FDA clearance and broad guideline support for use in survivorship care of at-risk cancer patients. The company continues to expand its commercial footprint through SaaS models and new clinical applications.
- Therapeutic areas
- NephrologyMetabolic DisordersCardiovascularOncology
- Modalities
- Device (Bioimpedance spectroscopy-based medical devices)Digital health platform
- Industry
- Physiological Monitoring
02
Partnerships
SWK Holdings ($15M growth capital facility)Armentum Partners (financial advisor)
Beyond the preview
Go deeper on ImpediMed.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ImpediMed.